Cerecor Культура компании

Ms. Mariam E. Morris, CPA has been the Chief Financial Officer at Cerecor Inc. since August 2015 and serves as its Secretary. Ms. Morris is the sole proprietor of Mariam Morris CPA, a full service tax, accounting and business consulting firm, which she founded in January 2009. She served as Consultant of Sucampo Pharmaceuticals Inc., since August 1, 2008. She served as the Chief Financial Officer and Treasurer of Sucampo Pharmaceuticals Inc., since March 2006 and also served as its Director of Finance since February 2004, where Ms. Morris was responsible for its financial reporting, related internal controls and the overall day-to-day operations of the accounting department. Ms. Morris served as the Chief Financial Officer of Sucampo Pharmaceuticals Inc. from January 2, 2008 to July 31, 2008 and also served as its Chief Accounting Officer from January 3, 2007 to June 5, 2008 and Secretary since April 2008. Ms. Morris served as an Independent Consultant of AuditWatch Inc., where she was involved in the technical training and education of both senior and entry level accountants for small to mid-sized accounting firms. Prior to that, she served as a Supervising Auditor of Snyder, Cohn, Collyer, Hamilton & Associates P.C. She served as a Senior Auditor of PricewaterhouseCoopers LLP from 1991 to 2001. She served six years in public accounting, where she specialized in servicing the needs of privately held growth companies. Ms. Morris has experience in financial reporting, auditing, consulting, tax preparation, transaction analysis and internal control assessments and compliance. Ms. Morris holds a BBA in Accounting from Texas Tech University and a Master's in Taxation from Old Dominion University. She is a Certified Public Accountant and is a Member of the AICPA and TSCPA.

Dr. Barbara S. Slusher Ph.D. is the Founder of Cerecor, Inc. Dr. Slusher served as Senior Vice President - Research Animals & Toxicology of Guilford Pharmaceuticals Inc. since August 2002. Dr. Slusher joined Guilford Pharmaceuticals Inc. in January 1995 as Principal Scientist and Group Leader in Research and Development. She served as Vice President, Biology of Guilford Pharmaceuticals Inc. since February 2000. She served as Senior Research Pharmacologist for Zeneca Pharmaceuticals Inc. since April 1992. She serves as a Member of Scientific Advisory Board at Cerecor, Inc. She received her Ph.D. in Pharmacology and Molecular Sciences from the Johns Hopkins School of Medicine in 1991 and her Master's degree in Management from the Johns Hopkins School of Continuing Studies in 1991. Dr. Slusher received her B.S. Degree in Chemistry from Dickinson College in 1986.

Dr. Solomon H. Snyder, M.D. served as a Consultant to Guilford Pharmaceuticals Inc. since August 1993. Dr. Snyder is a Senior Advisor of the Scientific Advisory Board of Red Abbey Venture Partners, LLC. He is the Founder of Cerecor Inc. and serves as its Chairman of Scientific Advisory Board. Dr. Snyder is a Co-Founder of Sova Pharmaceuticals, Inc., and serves as its Chairman of Scientific Advisory Board. He serves as Chairman of the Scientific Advisory Board at QRxPharma Limited. He serves as an Advisory Board Member at Camden Partners Holdings, LLC. He serves as an Advisory Board Member at Camden Partners Holdings, LLC. He serves as a Member of Advisory Board at Camden Partners Exelixis Fund, L.P. Dr. Snyder served as a Director of Guilford Pharmaceuticals Inc. since its inception in July 1993. Dr. Snyder was a Member of the Board of Directors of Scios, Inc. since April 2003. He helped start Nova Pharmaceuticals. He is Distinguished Service Professor of Neuroscience, Pharmacology and Psychiatry at the Johns Hopkins University School of Medicine. He served as Director of the Department of Neuroscience at The Johns Hopkins University School of Medicine from 1980 to 2006. He is the recipient of numerous professional honors, including the Albert Lasker Award for Basic Biomedical Research in 1978, the Wolf Foundation Prize in Medicine in 1983, the Dickson Prize of the University of Pittsburgh in 1983, the Bower Award from the Franklin Institute in 1991, the Bristol-Myers-Squibb Award for Distinguished Achievement in Neuroscience Research in 1996 and the Gerard Prize of the Society for Neuroscience in 2000. Dr. Snyder is the author of more than 1000 journal articles and several books, including Uses of Marijuana (1971), Madness and the Brain (1974), The Troubled Mind (1976), Biological Aspects of Abnormal Behavior (1980), Drugs and the Brain (1986), and Brainstorming (1989). In 1966, Dr. Snyder joined the staff of the Department of Pharmacology at The Johns Hopkins University School of Medicine. He received his undergraduate and medical training at Georgetown University and his psychiatric training at The Johns Hopkins University. He received Honorary Doctor of Science degrees from Northwestern University in 1981, Georgetown University in 1986, Ben Gurion University in 1990, Albany Medical College in 1998 and Technion University of Israel in 2002. Dr. Snyder is a graduate of Georgetown College and Georgetown Medical School in Washington, D.C.

Patrick C serves as the VP of Business Development of Cerecor Inc.. Patrick started at Cerecor Inc. in Sep of 2018. Patrick currently resides in the Greater New York City Area.

Perry Calias serves as the Chief Scientific Officer of Cerecor Inc.. Perry started at Cerecor Inc. in Jul of 2018. Perry currently resides in the Greater Boston Area.

Matt Phillips serves as the Chief Commercial Officer of Cerecor Inc.. Matt started at Cerecor Inc. in Nov of 2017. Matt currently resides in the Raleigh-Durham, North Carolina Area.

Jamie Harrell serves as the Executive Vice President Marketing and Investor Relations of Cerecor Inc.. Jamie currently resides in the Baltimore, Maryland Area.

Robert Swedberg serves as the VP Finance, Controller of Cerecor Inc.. Robert currently resides in the Washington D.C. Metro Area.